Who are the key players in North America HLA Typing Market industry?

Key players in the North America HLA Typing Market include Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, CareDx, Inc., QIAGEN N.V., and Illumina, Inc. These companies are recognized for their advanced molecular diagnostics, innovation in transplant diagnostics, and substantial investments in HLA typing technology and solutions.

What is the North America HLA Typing Market growth?

The North America HLA Typing Market has experienced robust growth, driven by rising demand for organ transplantation procedures and advancements in molecular diagnostic techniques. In 2023, companies like CareDx witnessed increased adoption of next-generation sequencing HLA typing platforms, further propelling market expansion.

Which segment accounted for the largest North America HLA Typing Market share?

The transplant diagnostics segment accounted for the largest share in the North America HLA Typing Market. This is attributed to the high prevalence of organ transplant procedures and active research in histocompatibility testing, ensuring improved donor-recipient matching to enhance transplantation outcomes.

What are the factors driving the North America HLA Typing Market?

Key drivers include the rising incidence of chronic diseases leading to organ failure, increasing organ transplantation rates, and technological advances in HLA typing, such as NGS-based assays. For example, Thermo Fisher Scientific has launched cutting-edge HLA typing solutions, supporting market growth.

Which type accounted for the largest North America HLA Typing Market share?

Molecular assay-based HLA typing accounted for the largest share in the market. This method, particularly next-generation sequencing (NGS), is preferred due to its high accuracy, scalability, and ability to provide detailed resolution of HLA alleles, fueling its widespread adoption in clinical settings.

Home Healthcare

North America HLA Typing Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

Name: North America HLA Typing Market
Brand: Bussiness Insights

North America HLA Typing Market Market: by Type (Molecular Assays, Non-Molecular Assays), Application (Transplantation, Research, Disease Diagnosis, Donor Screening, Drug Discovery, Others), Distribution Channels (Direct Tenders, Retail Sales, Online Sales, Distributors & Wholesalers, Hospital Pharmacies, Others), Technology (PCR-Based Molecular Assays, Sequencing-Based Molecular Assays, SSO-PCR, SSP-PCR, Non-Molecular Assays, Other Technologies), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025

Last Updated: 31-07-2025 | Format: PDF | Report ID:20506 | Author: Abhishek

RD TOC Segmentation Research Methodology Request For Free Sample Copy

North America HLA Typing Market Size, Share & Growth Analysis (2025-2035)

The North America HLA Typing Market is undergoing transformative growth, driven by technological advancements and rising demand for precise donor-recipient matching. Key players are innovating to offer faster, more accurate, and cost-effective HLA typing solutions. With the surge in organ transplants, adoption of sequencing-based assays, and strategic collaborations, the market is set for significant expansion over the next decade.

Latest Market Dynamics

Key Drivers

Rising number of organ transplants across North America is intensifying the need for accurate HLA typing to minimize rejection rates. For instance, Thermo Fisher Scientific has advanced solutions in molecular HLA typing catering to transplant centers.
Rapid adoption of next-generation sequencing (NGS) technologies is boosting the accuracy and throughput of HLA typing, as seen with

Increased integration of cloud-based data management for HLA typing labs, enabling secure and efficient sharing of patient genetic data, with QIAGEN investing in informatics solutions.
A growing focus on precision medicine is driving the uptake of high-resolution HLA typing for disease diagnosis and tailored therapies, highlighted by Roche's recent expansion in personalized healthcare services.

Expansion of HLA typing in disease association studies presents new avenues for growth, as genetics-based pharma companies like GenDx partner with research institutes.
Wider adoption of automated HLA typing systems in medium and large hospitals creates opportunities for vendors; Bio-Rad Laboratories recently launched user-friendly platforms targeting these institutions.

High cost of advanced HLA typing technologies remains a challenge for adoption, particularly for smaller labs. Many centers struggle to upgrade due to cost constraints, as acknowledged by CareDx in its 2024 disclosures.
Standardization of results across platforms and labs is lacking, leading to variability in interpretation. Companies like Abbott Laboratories are working towards harmonized solutions, but full industry-wide standardization is not yet achieved.

Stringent regulatory frameworks surrounding genetic testing in the US and Canada slow down new product launches, with companies including Becton Dickinson facing longer approval timelines.
Limited awareness and training for advanced HLA typing techniques also impede uptake outside major metropolitan medical centers. Smaller clinics and regional hospitals struggle to invest in workforce development despite available technology.

In 2025, molecular assays are expected to dominate the North America HLA Typing Market, driven by their unparalleled accuracy and role in transplantation and disease screening. Non-molecular assays, while still used, have a declining share as advanced technologies become mainstream. The market is rapidly shifting toward high-throughput and sequencing-based molecular assays for improved clinical outcomes. Laboratories are prioritizing methods with better sensitivity, leading to molecular assays consolidating the largest share, followed by non-molecular options and other emerging technologies.

Transplantation continues to represent the largest segment in the North America HLA Typing Market, accounting for the majority of market value in 2025 as demand for kidney, liver, and other organ transplants grows. Research applications and disease diagnosis are also showing steady increases, with genetic research institutes and clinical labs driving up utilization rates for precision medicine. Together, these segments highlight the critical role that accurate HLA typing plays in transplantation success and broader healthcare innovations across the United States and Canada.

The North America HLA Typing Market is projected to exhibit robust growth, with revenue expected to rise sharply from 2020 through 2035. The expansion is fueled by technological advancements, higher demand for organ transplants, and the integration of precision diagnosis into mainstream clinical practice. By 2025, the market is anticipated to surpass 800 million USD, with a compound annual growth rate accelerating through the forecast period as more healthcare providers embrace high-throughput molecular and sequencing-based HLA typing solutions.

Year-on-year growth in the North America HLA Typing Market is expected to accelerate from 2020 to 2035, driven by the adoption of sophisticated technologies and increased investment across healthcare networks. After a steady rise in early years, post-2025 growth is projected to be stronger due to ongoing technological innovations and a surge in transplant-related procedures. The market's resilience is underscored by its ability to adapt to regulatory, economic, and scientific developments, contributing to a positive and sustainable revenue outlook.

The United States dominates the North America HLA Typing Market, accounting for the lion’s share due to its extensive healthcare infrastructure, research investment, and high transplant rates. Canada and Mexico, while smaller, are experiencing faster adoption of molecular HLA typing technologies, particularly in metropolitan centers. As these countries increase healthcare spending and improve transplant programs, their market shares are expected to rise, though the U.S. will maintain clear leadership over the next decade.

Thermo Fisher Scientific, Bio-Rad Laboratories, and QIAGEN N.V. collectively represent the largest proportion of the North America HLA Typing Market in 2025, supported by robust R&D, product innovation, and distribution networks. These leaders are closely followed by Illumina, Inc. and GenDx, who are rapidly expanding their presence with advanced sequencing and digital HLA solutions. The competitive landscape is characterized by ongoing alliances, new launches, and strategic acquisitions that further concentrate market share among the top players.

Hospital and transplant centers account for the highest share of HLA typing solutions purchased in North America, reflecting the critical role of these institutions in patient diagnosis and treatment. Research institutes and reference laboratories are also major buyers, leveraging advanced HLA typing for clinical studies and personalized medicine. Together, these groups underscore the market’s focus on providing life-saving, high-accuracy tests both in critical care and research environments.

Metrics	Details
Years	2020-2035
Base Year	2025
Market Size	820
Regions	United States, Canada, Mexico
Segments	By Type (Molecular Assays, Non-Molecular Assays), By Application (Transplantation, Research, Disease Diagnosis, Donor Screening, Drug Discovery, Others), By Distribution Channel (Direct Tenders, Retail Sales, Online Sales, Distributors & Wholesalers, Hospital Pharmacies, Others), By Technology (PCR-Based Molecular Assays, Sequencing-Based Molecular Assays, SSO-PCR, SSP-PCR, Non-Molecular Assays, Other Technologies), By Organization Size (Small, Medium, Large)
Players	Thermo Fisher Scientific, Bio-Rad Laboratories, QIAGEN N.V., Illumina, Inc., GenDx, F. Hoffmann-La Roche AG, CareDx, Immucor, Inc., BioFortuna Limited, Takara Bio Inc., Becton, Dickinson and Company, Luminex Corporation, Abbott Laboratories, Omixon Inc., Agilent Technologies

June 2024: Thermo Fisher Scientific announced the launch of a high-throughput NGS-based HLA typing platform designed to accelerate organ transplant matching.
July 2024: Bio-Rad Laboratories entered a strategic alliance with a leading university hospital in Canada to expand automated HLA typing adoption.
August 2024: Illumina, Inc. released updated software for faster, more precise HLA sequencing analysis, aimed at supporting clinical workflows.
September 2024: QIAGEN N.V. announced a collaboration with major U.S. transplant centers to pilot AI-driven HLA typing analytics.
October 2024: GenDx received FDA clearance for its new digital HLA typing kit, paving the way for broader clinical deployment across North America.

About the Author

Abhishek

Senior Market Research Analyst

Abhishek is a Senior Market Research Analyst specializing in market research, industry analysis, and business consulting across Healthcare. Abhishek brings a commercially grounded perspective to sectors shaped by changing demand, innovation, and competitive dynamics, helping turn complex market trends into clear strategic insights for business decision-makers. With 10+ years of experience across research, analytics, and strategic advisory roles, Abhishek has helped organizations translate data into actionable growth strategies.

HealthcareMarket ResearchIndustry AnalysisStrategic Consulting

Key Questions Answered

»What is the market size and growth rate of the global and regional market by various segments?
»What is the market size and growth rate of the market for selective countries?
»Which region or sub-segment is expected to drive the market in the forecast period?
»What factors are estimated to drive and restrain the market growth?
»What are the key technological and market trends shaping the market?
»What are the key opportunities in the market?
»What are the key companies operating in the market?
»Which company accounted for the highest market share?

Download Sample

Why Choose Bussiness Insights?

»Strong Industry Focus
»Extensive Product Offerings
»Customer Research Services
»Robust Research Methodology
»Comprehensive Reports
»Latest Technological Developments
»Value Chain Analysis
»Potential Market Opportunities
»Growth Dynamics
»Quality Assurance
»Post-sales Support
»Regular Report Updates

Speak to Analyst

North America HLA Typing Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

North America HLA Typing Market Size, Share & Growth Analysis (2025-2035)

Latest Market Dynamics

Key Drivers

Key Trends

Key Opportunities

Key Challenges

Key Restraints

North America HLA Typing Market Share by Type (2025)

North America HLA Typing Market Share by Applications (2025)

North America HLA Typing Market Revenue (USD Million), 2020-2035

North America HLA Typing Market YOY Growth (%), 2020-2035

North America HLA Typing Market Share by Region, 2025

North America HLA Typing Market Players Share, 2025

North America HLA Typing Market Buyers Share, 2025

Study Coverage

Key Recent Developments

Frequently Asked Questions

About the Author

Related Reports